Safety and protection of plasma donors: A scoping review and evidence gap map.

Autor: Schroyens N; Centre for Evidence-Based Practice, Belgian Red Cross, Mechelen, Belgium.; Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium., D'aes T; Centre for Evidence-Based Practice, Belgian Red Cross, Mechelen, Belgium., De Buck E; Centre for Evidence-Based Practice, Belgian Red Cross, Mechelen, Belgium.; Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium., Mikkelsen S; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark., Tiberghien P; Etablissement Français du Sang, Saint-Denis, France.; Université de Franche-Comté, EFS, INSERM, UMR Right, Besançon, France., van den Hurk K; Donor Medicine Research - Donor Studies, Sanquin Research, Amsterdam, The Netherlands.; Department of Public and Occupational Health, Amsterdam Public Health research institute, Amsterdam UMC, Amsterdam, The Netherlands., Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Compernolle V; Belgian Red Cross, Blood Services, Mechelen, Belgium.; Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium., Van Remoortel H; Centre for Evidence-Based Practice, Belgian Red Cross, Mechelen, Belgium.; Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Jazyk: angličtina
Zdroj: Vox sanguinis [Vox Sang] 2024 Feb; Vol. 119 (2), pp. 110-120. Date of Electronic Publication: 2023 Oct 10.
DOI: 10.1111/vox.13544
Abstrakt: Background and Objectives: As part of a large-scale project to safely increase plasma collection in Europe, the current scoping review identifies the existing evidence (gaps) on adverse events (AEs) and other health effects in plasmapheresis donors, as well as factors that may be associated with such events/effects.
Materials and Methods: We searched six databases and three registries. Study characteristics (publication type, language, study design, population, outcomes, associated factors, time of assessment, duration of follow-up, number and frequency of donations, convalescent plasma [y/n], setting and location) were synthesized narratively and in an interactive evidence gap map (EGM).
Results: Ninety-four research articles and five registrations were identified. Around 90% were observational studies (57 controlled and 33 uncontrolled), and most of them were performed in Europe (55%) or the United States (20%). Factors studied in association with donor health included donor characteristics (e.g., sex, age) (n = 27), cumulative number of donations (n = 21), donation frequency (n = 11), plasma collection device or programme (n = 11), donor status (first time vs. repeat) (n = 10), donation volume per session (n = 8), time in donation programme (n = 3), preventive measures (n = 2) or other (n = 9).
Conclusion: The current scoping review provides an accessible tool for researchers and policymakers to identify the available evidence (gaps) concerning plasmapheresis donation safety. Controlled prospective studies with long-term donor follow-up are scarce. Furthermore, additional experimental studies comparing the health effects of different donation frequencies are required to inform a safe upper limit for donation frequency.
(© 2023 International Society of Blood Transfusion.)
Databáze: MEDLINE
Externí odkaz: